Sort
85,873 grants matching “alzheimers”
Genetic Drivers of Resilience to Alzheimer's Disease
$776,683Timothy J Hohman · Vanderbilt University Medical Center · R01 · FY2022 · AG
Defining the role of keratan sulfate recognition in Alzheimer's Disease progression
$776,544Robert J Woods · University Of Georgia · R56 · FY2018 · AG
Perivascular Inflammation and Vascular Remodeling: A Common Cause of Hemorrhage in Cerebral Small Vessel Diseases?
$776,503Susanne Janneke Van Veluw · Massachusetts General Hospital · R56 · FY2023 · NS
Chemogenetic neurovascular oxidative stress: neurodegeneration and cardiac remodeling
$776,474Thomas Michel · Brigham And Women'S Hospital · R01 · FY2024 · NS
Understanding and Addressing Disparities in Primary Care: A National Mixed Methods Study
$776,471Karen E. Schifferdecker · Dartmouth College · R01 · FY2025 · AG
Whole-brain fluorescence and brightfield imaging at single-cell level
$776,467Pixuan Zhou · Dmetrix, Inc. · R44 · FY2014 · AG
The Role of Bilingualism in Cognitive and Brain Resilience: Addressing the Complexity
$776,431Jessica Anne Deleon · University Of California, San Francisco · R01 · FY2024 · AG
AI-Enhanced Brain PET Imaging for Alzheimer's Disease
$776,426Gregory George Zaharchuk · Stanford University · R56 · FY2023 · AG
Mechanisms of Resilience to Alzheimer's Disease Neuropathology
$776,425Giulio Taglialatela · University Of Texas Med Br Galveston · R56 · FY2019 · AG
Impaired Vasoreactivity, Sleep Degradation, and Impaired Clearance in the APOE4 Brain
$776,419Elizabeth A Proctor · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2022 · AG
Social security: The influence of social relationships on cognitive, affective, and neural aging
$776,416Eliza Bliss-Moreau · University Of California At Davis · R56 · FY2022 · AG
Efficacy and Mechanisms of Combined Aerobic Exercise and Cognitive Training in MCI (The ACT Trial)
$776,403Fang Yu · University Of Minnesota · R01 · FY2017 · AG
Mechanisms of exposure-induced tissue functional and pathological changes in a mouse model of Alzheimer's Disease
$776,382Loren Eugene Wold · Ohio State University · R01 · FY2019 · AG
Imaging Epigenetic Mechanisms in the Lewy Body Dementias with [11C]Martinostat
$776,355Stephen N. Gomperts · Massachusetts General Hospital · R56 · FY2021 · AG
A Biomedical Mass Spectrometry Resource: Ongoing Driving Biomedical Projects
$776,346Michael L Gross · Washington University · R24 · FY2021 · GM
Genomics-guided sleep biomarker discovery for early Alzheimer's disease: A wearables study
$776,284Joyita Dutta · University Of Massachusetts Amherst · R01 · FY2024 · AG
CommunityRx-Dementia
$776,220Stacy Tessler Lindau · University Of Chicago · R01 · FY2021 · AG
Autoimmune features of neurodegenerative disorders
$776,164David Sulzer · Columbia University Health Sciences · R01 · FY2022 · NS
Allopregnanolone a Regenerative Therapy for Alzheimer's: FDA-Required Toxicolog
$776,163Roberta Diaz Brinton · University Of Southern California · U01 · FY2015 · AG
Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism
$776,088Byoung-Joon Song · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2011 · AA
Assessing Diffusion MRI Metrics for Detecting Changes of Synaptic Density in Alzheimer's Disease
$776,084Yu-Chien Wu · Indiana University Indianapolis · R01 · FY2024 · AG
Staging primary tauopathies with tau proteoforms
$776,051Chihiro Sato · Washington University · R01 · FY2024 · AG
Building a shared infrastructure for cognitive assessment in the service of cognitive training research
$776,015Aaron R Seitz · Northeastern University · R33 · FY2025 · AG
Emotion alterations across the Alzheimer's disease spectrum
$776,015Virginia Emily Sturm · University Of California, San Francisco · R01 · FY2025 · AG
Endosome Dysfunction in Alzheimer's Disease
$775,998Ralph A. Nixon · New York University School Of Medicine · R01 · FY2018 · AG